Effects of metoprolol and carvedilol on pre‐existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET)

BACKGROUND: β Blocker treatment may worsen glucose metabolism. OBJECTIVE: To study the development of new onset diabetes in a large cohort of patients with heart failure treated with either metoprolol or carvedilol. DESIGN: Prospective and retrospective analysis of a controlled clinical trial. SETTI...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Torp‐Pedersen, Christian, Metra, Marco, Charlesworth, Andrew, Spark, Phillip, Lukas, Mary Ann, Poole‐Wilson, Philip A, Swedberg, Karl, Cleland, John G F, Lenarda, Andrea Di, Remme, Willem J, Scherhag, Armin
Format: Artigo
Jezik:Inglês
Izdano: BMJ Group 2007
Teme:
Diabetes, Lipids and Metabolism
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC1994413/
https://ncbi.nlm.nih.gov/pubmed/17237130
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/hrt.2006.092379
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items